Bruker (FRA:BKD) Long-Term Debt: €1,438 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BKD Bruker Corp FRA:BKD
86 GF Score
Price €51.50
GF Value €55.57
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Bruker Long-Term Debt?

Bruker FRA:BKD +1.36% 86 Long-Term Debt is €1,438 Mil as of Mar. 2026. GuruFocus rates FRA:BKD with a GF Score™ of 86/100 and a GF Value™ of €55.57 (Fairly Valued). The stock has 10 warning signs investors should review.

Bruker's Long-Term Debt for the quarter that ended in Mar. 2026 was €1,438 Mil.

Bruker's quarterly Long-Term Debt declined from Sep. 2025 (€1,691 Mil) to Dec. 2025 (€1,582 Mil) and declined from Dec. 2025 (€1,582 Mil) to Mar. 2026 (€1,438 Mil).

Bruker's annual Long-Term Debt increased from Dec. 2023 (€1,064 Mil) to Dec. 2024 (€1,969 Mil) but then declined from Dec. 2024 (€1,969 Mil) to Dec. 2025 (€1,582 Mil).

Bruker  (FRA:BKD) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Bruker Long-Term Debt Related Terms

Bruker Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Bruker's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker Long-Term Debt Chart

Bruker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,081.29 1,133.27 1,064.00 1,969.02 1,582.04

Bruker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,920.39 2,063.11 1,690.54 1,582.04 1,438.41
FRA:BKD
86GF Score
Bruker Corp FRA:BKD
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €1,438 Mil mean?
Bruker (FRA:BKD) has a Long-Term Debt of €1,438 Mil as of Mar. 2026.
Is Bruker's Long-Term Debt too high?
Bruker's current Long-Term Debt is €1,438 Mil. Overall, Bruker has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's Long-Term Debt compare to GKOS and BIO?
Bruker's Long-Term Debt of €1,438 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Bruker's current Long-Term Debt is €1,438 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €55.57, compared to a current price of €51.50 — trading 7.3% below its estimated fair value. The current Long-Term Debt is €1,438 Mil. Bruker's overall GF Score™ is 86/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Bruker (FRA:BKD), the current Long-Term Debt is €1,438 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bruker (FRA:BKD) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of €51.50 is trading 7.3% below its estimated GF Value™ of €55.57. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for FRA:BKD:

  • Long-Term Debt: €1,438 Mil
  • GF Value™: €55.57 vs. price of €51.50 (7.3% below fair value)
  • GF Score™: 86/100 with 10 warning signs

No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
86GF Score

Get the complete analysis for FRA:BKD

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.50
Price
€55.57
GF Value